{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:03:38Z","timestamp":1790503418447,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd012972","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T00:00:00Z","timestamp":1620259200000}}],"reference-count":81,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012972.pub2","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T21:34:06Z","timestamp":1620336846000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of the diagnostic test Xpert MTB\/RIF on patient outcomes for tuberculosis"],"prefix":"10.1002","volume":"2021","author":[{"given":"Frederick","family":"Haraka","sequence":"additional","affiliation":[{"name":"Elizabeth Glaser Pediatric AIDS Foundation; Dar es Salaam Tanzania"},{"name":"Ifakara Health Institute; Bagamoyo Tanzania"},{"name":"University of Basel; Basel Switzerland"},{"name":"Swiss Tropical and Public Health Institute; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mwaka","family":"Kakolwa","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute; Dodoma Tanzania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel G","family":"Schumacher","sequence":"additional","affiliation":[{"name":"FIND; Geneva Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruvandhi R","family":"Nathavitharana","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases; Beth Israel Deaconess Medical Center, Harvard Medical School; Boston USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia M","family":"Denkinger","sequence":"additional","affiliation":[{"name":"FIND; Geneva Switzerland"},{"name":"Division of Tropical Medicine, Centre for Infectious Diseases; University Hospital Heidelberg; Heidelberg Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Gagneux","sequence":"additional","affiliation":[{"name":"University of Basel; Basel Switzerland"},{"name":"Swiss Tropical and Public Health Institute; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Reither","sequence":"additional","affiliation":[{"name":"Ifakara Health Institute; Bagamoyo Tanzania"},{"name":"University of Basel; Basel Switzerland"},{"name":"Swiss Tropical and Public Health Institute; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Ross","sequence":"additional","affiliation":[{"name":"University of Basel; Basel Switzerland"},{"name":"Swiss Tropical and Public Health Institute; Basel Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"10.1002\/14651858.CD012972.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1186\/s12879-019-4697-5","article-title":"Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB\/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial","volume":"19","author":"Agizew","year":"2019","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S2213-2600(15)00198-8","article-title":"Burden of tuberculosis in intensive care units in Cape Town, South Africa, and assessment of the accuracy and effect on patient outcomes of the Xpert MTB\/RIF test on tracheal aspirate samples for diagnosis of pulmonary tuberculosis: a prospective burden of disease study with a nested randomised controlled trial","volume":"3","author":"Calligaro","year":"2015","journal-title":"Lancet Respiratory Medicine"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1016\/S2214-109X(15)00100-X","article-title":"Xpert MTB\/RIF versus sputum microscopy as the initial diagnostic test for tuberculosis: a cluster-randomised trial embedded in South African roll-out of Xpert MTB\/RIF","volume":"3","author":"Churchyard","year":"2015","journal-title":"Lancet. Global Health"},{"issue":"11","key":"10.1002\/14651858.CD012972.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"e1001760","DOI":"10.1371\/journal.pmed.1001760","article-title":"Impact of Xpert MTB\/RIF for TB diagnosis in a primary care clinic with high TB and HIV prevalence in South Africa: a pragmatic randomised trial","volume":"11","author":"Cox","year":"2014","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(18)30458-3","article-title":"Effect of MTB\/RIF on clinical outcomes in routine care settings: individual patient data meta-analysis","volume":"7","author":"Di Tanna","year":"2019","journal-title":"Lancet. Global Health"},{"issue":"12","key":"10.1002\/14651858.CD012972.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"e1001766","DOI":"10.1371\/journal.pmed.1001766","article-title":"Impact of replacing smear microscopy with Xpert MTB\/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomised trial","volume":"11","author":"Durovni","year":"2014","journal-title":"PLoS Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012972.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"e0123252","DOI":"10.1371\/journal.pone.0123252","article-title":"Impact on patients' treatment outcomes of Xpert MTB\/RIF implementation for the diagnosis of tuberculosis: follow-up of a stepped-wedge randomized clinical trial","volume":"10","author":"Trajman","year":"2015","journal-title":"PloS One"},{"issue":"1","key":"10.1002\/14651858.CD012972.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ofid\/ofu038","article-title":"Impact of Xpert MTB\/RIF on antiretroviral therapy-associated tuberculosis and mortality: a pragmatic randomised controlled trial","volume":"1","author":"Mupfumi","year":"2014","journal-title":"Open Forum Infectious Diseases"},{"issue":"7","key":"10.1002\/14651858.CD012972.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1093\/cid\/ciy590","article-title":"Screening for tuberculosis with Xpert MTB\/RIF assay versus fluorescent microscopy among adults newly diagnosed with human immunodeficiency virus in rural Malawi: a cluster randomised trial (Chepetsa)","volume":"68","author":"Ngwira","year":"2019","journal-title":"Clinical Infectious Diseases"},{"issue":"12","key":"10.1002\/14651858.CD012972.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.7196\/SAMJ.2017.v107i12.12502","article-title":"Impact of Xpert MTB\/RIF rollout on management of tuberculosis in a South African community","volume":"107","author":"Geldenhuys","year":"2017","journal-title":"South African Medical Journal"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0140-6736(13)62073-5","article-title":"Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB\/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial","volume":"383","author":"Theron","year":"2014","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD012972.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5588\/ijtld.14.0653","article-title":"The impact of Xpert MTB\/RIF in sparsely populated rural settings","volume":"19","author":"Van den Handel","year":"2015","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"6","key":"10.1002\/14651858.CD012972.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"e0123536","DOI":"10.1371\/journal.pone.0123536","article-title":"Effects of introducing Xpert MTB\/RIF on diagnosis and treatment of drug-resistant tuberculosis patients in Indonesia: a pre-post intervention study","volume":"10","author":"Kampfen","year":"2015","journal-title":"PloS One"},{"issue":"11","key":"10.1002\/14651858.CD012972.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"e48599","DOI":"10.1371\/journal.pone.0048599","article-title":"Impact of Xpert MTB\/RIF testing on tuberculosis management and outcomes in hospitalised patients in Uganda","volume":"7","author":"Yoon","year":"2012","journal-title":"PloS One"},{"issue":"9776","key":"10.1002\/14651858.CD012972.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study","volume":"377","author":"Boehme","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD012972.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.5588\/ijtld.13.0747","article-title":"Impact of the Xpert(\u00ae) MTB\/RIF molecular test on the late diagnosis of pulmonary tuberculosis","volume":"18","author":"Buchelli Ramirez","year":"2014","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"1","key":"10.1002\/14651858.CD012972.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5588\/pha.19.0059","article-title":"Pre-treatment lost to follow-up tuberculosis patients, Chongwe, Zambia, 2017: a retrospective cohort study","volume":"10","author":"Chilembo","year":"2020","journal-title":"Public Health Action"},{"issue":"7","key":"10.1002\/14651858.CD012972.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1128\/JCM.00330-13","article-title":"Evaluation of Xpert MTB\/RIF for detection of tuberculosis from blood samples of HIV-infected adults confirms Mycobacterium tuberculosis bacteremia as an indicator of poor prognosis","volume":"51","author":"Feasey","year":"2013","journal-title":"Journal of Clinical Microbiology"},{"issue":"6","key":"10.1002\/14651858.CD012972.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"e65421","DOI":"10.1371\/journal.pone.0065421","article-title":"Time to treatment and patient outcomes among TB suspects screened by a single point of care Xpert MTB\/RIF at primary care clinic in Johannesburg, South Africa","volume":"8","author":"Hanrahan","year":"2013","journal-title":"PloS One"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"ofw068","DOI":"10.1093\/ofid\/ofw068","article-title":"Implementation of Xpert MTB\/RIF in Uganda: missed opportunities to improve the diagnosis of tuberculosis","volume":"3","author":"Hanrahan","year":"2016","journal-title":"Open Forum Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD012972.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.5588\/ijtld.15.0183","article-title":"Evaluation of Xpert(\u00ae) MTB\/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis","volume":"19","author":"Kim","year":"2015","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"10","key":"10.1002\/14651858.CD012972.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"e77456","DOI":"10.1371\/journal.pone.0077456","article-title":"Diagnostic accuracy and turnaround time of the Xpert MTB\/RIF assay in routine clinical practice","volume":"8","author":"Kwak","year":"2013","journal-title":"PloS One"},{"issue":"7","key":"10.1002\/14651858.CD012972.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"e1001067","DOI":"10.1371\/journal.pmed.1001067","article-title":"Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB\/RIF assay: a prospective study","volume":"8","author":"Lawn","year":"2011","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"4282313","DOI":"10.1155\/2016\/4282313","article-title":"The use of Xpert MTB\/Rif for active case finding TB contacts in North West Province, South Africa","volume":"2016","author":"Lebina","year":"2016","journal-title":"Tuberculosis Research and Treatment"},{"issue":"7","key":"10.1002\/14651858.CD012972.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1164\/rccm.201702-0278OC","article-title":"Impact of point-of-care Xpert MTB\/RIF on tuberculosis treatment initiation: a cluster-randomized trial","volume":"196","author":"Lessells","year":"2017","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5588\/ijtld.15.0177","article-title":"Xpert(\u00ae) MTB\/RIF for smear-negative presumptive TB: impact on case notification in DR Congo","volume":"20","author":"Mbonze","year":"2016","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"7","key":"10.1002\/14651858.CD012972.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"882","DOI":"10.5588\/ijtld.15.0696","article-title":"Xpert MTB\/RIF detection of rifampicin resistance and time to treatment initiation in Harare, Zimbabwe","volume":"20","author":"Metcalfe","year":"2016","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"1","key":"10.1002\/14651858.CD012972.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"e0168659","DOI":"10.1371\/journal.pone.0168659","article-title":"Microbiologically confirmed tuberculosis: factors associated with pre-treatment loss to follow-up, and time to treatment initiation","volume":"12","author":"Mwansa-Kambafwile","year":"2016","journal-title":"PloS One"},{"issue":"9","key":"10.1002\/14651858.CD012972.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/cid\/cis631","article-title":"Evaluation of the Xpert MTB\/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic","volume":"55","author":"O'Grady","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD012972.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/QAI.0000000000001110","article-title":"Implementation and Operational Research: clinical impact of the Xpert MTB\/RIF assay in patients with multidrug-resistant tuberculosis","volume":"73","author":"Roe O\u2019Donnell","year":"2016","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"6","key":"10.1002\/14651858.CD012972.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"e204558","DOI":"10.1371\/journal.pone.0020458","article-title":"Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Ceipheid Xpert MTB\/RIF assay - a clinical validation study","volume":"6","author":"Rachow","year":"2011","journal-title":"PloS One"},{"issue":"5","key":"10.1002\/14651858.CD012972.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"e0126065","DOI":"10.1371\/journal.pone.0126065","article-title":"Use of Xpert MTB\/RIF in decentralized public health settings and its effect on pulmonary TB and DR-TB case finding in India","volume":"10","author":"Sachdeva","year":"2015","journal-title":"PloS One"},{"issue":"7","key":"10.1002\/14651858.CD012972.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"e1001061","DOI":"10.1371\/journal.pmed.1001061","article-title":"Comparison of Xpert MTB\/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study","volume":"8","author":"Scott","year":"2011","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012972.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1164\/rccm.201101-0056OC","article-title":"Evaluation of the Xpert MTB\/RIF assay for diagnosing of pulmonary tuberculosis in a high prevalence setting","volume":"184","author":"Theron","year":"2011","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.21037\/apm.2020.02.17","article-title":"Effect of Xpert MTB\/RIF on the treatment of multi-drug-resistant or rifampicin-resistant tuberculosis screened out from re-treatment pulmonary tuberculosis patients, a prospective cohort study","volume":"9","author":"Wang","year":"2020","journal-title":"Annals of Palliative Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012972.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.5588\/ijtld.18.0203","article-title":"Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis","volume":"23","author":"Agizew","year":"2019","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1183\/13993003.00543-2016","article-title":"Development, roll-out and impact of Xpert MTB\/RIF for tuberculosis: what lessons have we learnt and how can we do better?","volume":"48","author":"Albert","year":"2016","journal-title":"European Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD012972.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/trstmh\/trw056","article-title":"Xpert MTB\/RIF - why the lack of morbidity and mortality impact in intervention trials?","volume":"110","author":"Auld","year":"2016","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD012972.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"54","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD012972.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012972.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5588\/ijtld.16.0801","article-title":"Why do clinical trials of Xpert\u00ae MTB\/RIF fail to show an effect on patient relevant outcomes?","volume":"21","author":"Boyles","year":"2017","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0042|cit42","volume-title":"Manson's Tropical Diseases","author":"Cook","year":"2008"},{"issue":"9514","key":"10.1002\/14651858.CD012972.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0140-6736(06)68383-9","article-title":"Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment","volume":"367","author":"Corbett","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-14-2","article-title":"Results from early programmatic implementation of Xpert MTB\/RIF testing in nine countries","volume":"14","author":"Creswell","year":"2014","journal-title":"BMC Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD012972.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.5588\/ijtld.14.0775","article-title":"Introducing new tuberculosis diagnostics: the impact of Xpert MTB\/RIF testing on case notifications in Nepal","volume":"19","author":"Creswell","year":"2015","journal-title":"International Journal of Tuberculosis and Lung Disease"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1183\/09031936.00007814","article-title":"Xpert MTB\/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis","volume":"44","author":"Denkinger","year":"2014","journal-title":"European Respiratory Journal"},{"issue":"35","key":"10.1002\/14651858.CD012972.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12874-016-0287-z","article-title":"Test-treatment RCTs are susceptible to bias: a review of the methodological quality of randomized trials that evaluate diagnostic tests","volume":"17","author":"di Ruffano","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"32","key":"10.1002\/14651858.CD012972.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12874-016-0286-0","article-title":"Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions","volume":"17","author":"di Ruffano","year":"2017","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0049|cit49","unstructured":"Suggested risk of bias criteria for EPOC reviews 2018 Available at epoc.cochrane.org\/epoc-resources-review-authors"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"g5360","DOI":"10.1136\/bmj.g5630","article-title":"A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0051|cit51","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT 2020"},{"issue":"4","key":"10.1002\/14651858.CD012972.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","article-title":"GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012972.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/JCM.01463-09","article-title":"Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology","volume":"48","author":"Helb","year":"2010","journal-title":"Journal of Clinical Microbiology"},{"issue":"8","key":"10.1002\/14651858.CD012972.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"554","DOI":"10.2471\/BLT.16.185314","article-title":"The impact of the roll-out of rapid molecular diagnostic testing for tuberculosis on empirical treatment in Cape Town, South Africa","volume":"95","author":"Hermans","year":"2017","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0056|cit56","doi-asserted-by":"crossref","unstructured":"Higgins JPT \u00a0Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch8"},{"issue":"10","key":"10.1002\/14651858.CD012972.pub2-BIB0057|cit57","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Medicine"},{"issue":"7303","key":"10.1002\/14651858.CD012972.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Systematic reviews in health care: assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD012972.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.95.6.1193","article-title":"A reevaluation of sputum microscopy and culture in the diagnosis of pulmonary tuberculosis","volume":"95","author":"Levy","year":"1989","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2471\/BLT.13.124800","article-title":"Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis","volume":"92","author":"MacPherson","year":"2014","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/bimj.201900036","article-title":"Meta-analysis of the difference of medians","volume":"62","author":"McGrath","year":"2020","journal-title":"Biometrical Journal"},{"issue":"7","key":"10.1002\/14651858.CD012972.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"e25162","DOI":"10.1002\/jia2.25162","article-title":"High HIV and active tuberculosis prevalence and increased mortality risk in adults with symptoms of TB: a systematic review and meta-analyses","volume":"21","author":"Nliwasa","year":"2018","journal-title":"Journal of the International AIDS Society"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"173","DOI":"10.12688\/wellcomeopenres.15412.1","article-title":"Variation in the observed effect of Xpert MTB\/RIF testing for tuberculosis on mortality: a systematic review and analysis of trial design considerations","volume":"4","author":"Ochodo","year":"2019","journal-title":"Wellcome Open Research"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Page MJ HIggins JPT Sterne JAC Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604.ch13"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"e000755","DOI":"10.1136\/bmjgh-2018-000755","article-title":"Surrogate endpoints in global health research: still searching for killer apps and silver bullets?","volume":"3","author":"Pai","year":"2018","journal-title":"BMJ Global Health"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0066|cit66","first-page":"314","article-title":"Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities","volume":"24","author":"Parsons","year":"2011","journal-title":"American Society of Microbiology"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0067|cit67","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0068|cit68","unstructured":"The Cochrane Collaboration Review Manager Web (RevMan Web) 2020"},{"issue":"3","key":"10.1002\/14651858.CD012972.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"e0151073","DOI":"10.1371\/journal.pone.0151073","article-title":"Impact of molecular diagnostics for tuberculosis on patient-important outcomes: a systematic review of study methodologies","volume":"11","author":"Schumacher","year":"2016","journal-title":"PloS One"},{"issue":"6","key":"10.1002\/14651858.CD012972.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1128\/JCM.03553-13","article-title":"Diagnostic accuracy of Xpert MTB\/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa","volume":"52","author":"Scott","year":"2014","journal-title":"Journal of Clinical Microbiology"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e1002754","DOI":"10.1371\/journal.pmed.1002754","article-title":"Constructing care cascades for active tuberculosis: a strategy for program monitoring and identifying gaps in quality of care","volume":"16","author":"Subbaraman","year":"2019","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1473-3099(13)70360-8","article-title":"Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings?","volume":"14","author":"Theron","year":"2014","journal-title":"Lancet Infectious Diseases"},{"issue":"13","key":"10.1002\/14651858.CD012972.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/1471-2334-13-507","article-title":"Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis","volume":"30","author":"Walusimbi","year":"2013","journal-title":"BMC Infectious Diseases"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0074|cit74","unstructured":"World Health Organization (WHO) Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB\/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update apps.who.int\/iris\/bitstream\/10665\/112472\/1\/9789241506335_eng.pdf 2013"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0075|cit75","unstructured":"World Health Organization (WHO) Xpert MTB\/RIF implementation manual. Technical and operational \u2018how-to\u2019: practical considerations Available at www.who.int\/tb\/publications\/xpert_implem_manual\/en\/ 2014"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0076|cit76","unstructured":"World Health Organization (WHO) The End TB strategy - Global strategy and targets for tuberculosis prevention, care and control after 2015 www.who.int\/tb\/strategy\/End_TB_Strategy.pdf"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0077|cit77","unstructured":"World Health Organization (WHO) The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin Available at www.who.int\/tb\/publications\/molecular-test-resistance\/en\/ 2016"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0078|cit78","unstructured":"World Health Organization (WHO) WHO monitoring of Xpert MTB\/RIF roll-out Available at www.who.int\/tb\/areas-of-work\/laboratory\/mtb-rif-rollout\/en\/ 2016"},{"key":"10.1002\/14651858.CD012972.pub2-BIB0079|cit79","unstructured":"World Health Organization (WHO) Global report for tuberculosis Available at www.who.int\/tb\/publications\/global_report\/en\/ 2019"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009593.pub5","article-title":"Xpert Ultra versus Xpert MTB\/RIF for pulmonary tuberculosis and rifampicin resistance in adults with presumptive pulmonary tuberculosis","author":"Schiller","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD012972.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012972","article-title":"Impact of diagnostic test Xpert MTB\/RIF\u00ae on health outcomes for tuberculosis","author":"Haraka","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T09:16:35Z","timestamp":1649063795000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012972.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":81,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012972.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}